BJ HEALTH released its interim results, with a loss attributable to shareholders of HKD 29.236 million, a year-on-year decrease of 48.17%
I'm PortAI, I can summarize articles.
BJ HEALTH released its interim results for the period ending June 30, 2025, with revenue of HKD 76.587 million, an increase of 4.47% year-on-year; the loss attributable to shareholders was HKD 29.236 million, a decrease of 48.17% year-on-year; basic loss per share was HKD 0.048. The revenue growth was mainly due to moderate growth in medical and elderly care products, particularly strong sales performance in the educational furniture product line
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments